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Trypanosoma cruzi, the etiological agent of Chagas disease, releases factors, including 
antigens from the trans-sialidase (TS) superfamily, which modulate the host immune 
responses. Tc13 antigens belong to group IV of TSs and are characterized by C-terminal 
EPKSA repeats. Here, we studied the effect of the Tc13 antigen from the Tulahuén strain, 
Tc13Tul, on primary cultures of splenocytes from naïve BALB/c mice. Recombinant 
Tc13Tul increased the percentage of viable cells and induced B (CD19+) lymphocyte 
proliferation. Tc13Tul stimulation also induced secretion of non-specific IgM and 
interferon-gamma (IFN-. The same effects were induced by Tc13Tul on splenocytes from 
naïve C3H/HeJ mice. In vivo administration of Tc13Tul to naïve BALB/c mice increased 
non-specific IgG in sera. In addition, in vitro cultured splenocytes from Tc13Tul-inoculated 
mice secreted a higher basal level of non-specific IgM than controls and the in vitro 
Tc13Tul stimulation of these cells showed an enhanced effect on IgM and IFN-secretion. 
Our results indicate that Tc13Tul may participate in the early immunity in T. cruzi infection 
by favoring immune system evasion through B-cell activation and non-specific Ig secretion. 
In contrast, as IFN- is an important factor involved in T. cruzi resistance, this may be 
considered a Tc13Tul effect in favor to the host. 
KEYWORDS: Chagas disease, immune evasion, excretory secretory antigen, B 
lymphocyte, trans-sialidase 
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Chagas disease is an endemic parasitosis of the American continent caused by the 
protozoan Trypanosoma cruzi, which affects 6 million people worldwide (WHO, 2018). As 
a consequence of migration processes, nowadays, T. cruzi infection represents a health 
problem not only in the Americas but also in non-endemic countries (Rassi et al., 2010). 
The acute phase of T. cruzi infection is characterized by polyclonal B-cell activation, 
hypergammaglobulinemia (Minoprio et al., 1998; Bryan
 
et al., 2010; Bermejo et al., 2011) 
and a strong humoral response against antigenic motifs that masks key catalytic domains 
relevant to the infection process (Alvarez
 
et al., 2001). Cumulative evidence has shown that 
T. cruzi expresses and sheds into the bloodstream immunomodulatory molecules which are 
involved in these events (Da Silva et al., 1998; Leguizamón et al., 1999; Reina-San-Martin 
et al., 2000; Ouaissi et al., 2002). Among them, antigens belonging to the trans-sialidase 
(TS) superfamily have been demonstrated to participate in: i- complement evasion 
(Beucher and Norris, 2008), ii- B-lymphocyte proliferation (Gao et al., 2002; Bermejo et 
al.,
 
2013), iii- apoptosis of immune cells (Leguizamón et al., 1999; Mucci et al.,
 
2006), iv- 
induction of non-neutralizing antibodies (Affranchino et al., 1989; Burns et al., 1992; 
Buscaglia et al., 1998) and v- evasion of protective immune responses through epitope 
variation (Wrightsman et al., 1994; Millar et al., 1999; Martin et al., 2006). These actions 
favor the delay in the generation of specific immunity, thus allowing the parasite to spread 
and persist in the mammalian host (Cardoso et al., 2016). 
The TS superfamily is the largest T. cruzi gene family, encoding more than 1,400 genes 
classified in eight groups (Freitas et al., 2011). It is worth noting that only group I contains 
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active trans-sialidases (TcTSs), which transfer sialic residues from host sialoconjugates to 
the parasite cell surface (Mucci et al., 2017). While TcTSs contain a Tyr342 which is crucial 
in the enzyme activity, all the other members of the TS superfamily show a Tyr342His 
replacement (Cremona
 
et al., 1995). These enzymatically inactive proteins (iTcTSs) retain a 
lectin-like activity (Cremona et al., 1999; Todeschini et al., 2002a) and it has been 
hypothesized that, in natural infection, they act mainly as virulence factors (Burgos et al., 
2013). Tc13 antigens, which are members of group IV of the TS superfamily, have not been 
largely studied so far. They are characterized by bearing five amino-acid (EPKSA) repeats 
at their C-terminal region (Campetella et al., 1992), which elicit a strong humoral response 
in T. cruzi-infected patients and mice, especially in the acute phase of the infection (Burns 
et al., 1992; Peralta et al., 1994; García et al., 2008; Santamaría et al., 2013). Genetic and 
recombinant immunizations of BALB/c mice with the Tc13 antigen of the Tulahuén strain 
of T. cruzi (Tc13Tul) have shown that Tc13 specific immunity does not confer protection 
against T. cruzi infection (García et al., 2006, García et al., 2008). Moreover, the high 
production of non-protective anti-EPKSA IgG in the acute phase of the infection, the 
presence of a weak anti-Tc13 memory T-cell response, and the lack of Tc13-specific CD4+ 
T-cells with ability to release IFN- in the chronic phase of the infection suggest that Tc13 
antigens are involved in mechanisms of evasion from host immunity (García et al., 2008). 
To test this hypothesis and obtain further information about primary immune responses 
triggered by Tc13 antigens on B and T lymphocytes, the aim of the present study was to 
evaluate the effect of Tc13Tul on the viability and lymphoproliferation of splenocytes from 
naïve mice in vitro. We also aimed to study Tc13Tul ability to induce polyclonal Ig 
production and cytokine secretion by in vitro and in vivo stimulation of these cells. 
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MATERIALS AND METHODS 
Ethical statement and Mice 
Animal studies were carried out with the approval of the Institutional Ethical Committee 
and conformed to the ethical treatment of animals established by the Argentinean Animal 
Protection Society. Six-week-old male naïve mice were used in all the experiments. 
BALB/c mice were maintained at the animal facility of INP “Dr. Fatala Chaben” in 
ventilated plastic cages with free access to tap water and enough rodent food. C3H/HeJ 
mice were kindly provided by Dr. Oscar Campetella from Instituto de Investigaciones 
Biotecnológicas-Universidad de San Martín (IIB-UNSAM), Buenos Aires, Argentina. For 
euthanasia, mice were subjected to cervical dislocation under anesthesia with 100 µl of a 
mixture of ketamine (50 mg/kg; Ketafine, Brouwer, CABA, Argentina) and xylazine (5 
mg/kg; Kensol, König, Avellaneda, BA, Argentina) delivered by intraperitoneal (i.p.) 
injection. 
Recombinant proteins 
Tc13Tul protein (GenBank Accession no. AF091620) was expressed as a maltose-binding 
protein (MBP) fusion, purified by amylose resin and filtrated with a 100kDa MW cut off 
centrifugal filter device (Centricon®, Millipore, Darmstadt, Germany) (García et al., 2003). 
The clone coding for EPKSA (GenBank Accession no. M92046) repeats fused to 
glutathione-S-transferase (GST) was kindly provided by Dr O. Campetella (IIB-UNSAM, 
Buenos Aires, Argentina). The GST-EPKSA recombinant protein was purified by 
glutathione-agarose resin. The homogeneity of the proteins was evaluated by sodium 
dodecyl sulfate-7.5% polyacrylamide gel electrophoresis (SDS-7.5% PAGE). 
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In vitro culture of splenocytes 
Mouse splenocytes depleted of erythrocytes were seeded in 96-well culture plates at 4x10
5
 
cells/well in 200 l of RPMI-10% fetal bovine serum (FBS) in the presence of either 
Tc13Tul (6 µg/10
6
 cells), MBP (2.2 µg/10
6
 cells), EPKSA (6 µg/10
6
 cells) or GST (1.5 
µg/10
6
 cells) and incubated at 37ºC with 5% CO2 for 24 to 72 h depending on each 
experiment conditions. For toll-like receptor 4 (TLR4) activation assays, 
lipopolysaccharide (LPS) (5 µg/ml) (Sigma-Aldrich, Saint Louis, MO, USA) and colistin 
(10 µg/ml) (Alficetin, Argentia, CABA, Argentina) were used. 
Cell viability evaluation 
Cell viability was assessed by staining with trypan blue or propidium iodide (PI). Trypan 
blue staining was evaluated by optical microscopy counting non-stained cells (live) in a 
Neubauer camera and the percentage of live cells was calculated considering the initial cell 
inoculum of 2x10
6
 cells/ml as 100%. PI staining was analyzed by flow cytometry and the 
percentage of live cells (PI negative) was calculated considering the total of 20,000 events 
acquired as 100%. 
Flow cytometry acquisition and analysis 
Splenocytes were acquired with a BD FACS Calibur flow cytometer (BD Biosciences, NJ, 
USA) and analyzed with FlowJo software (Tree Star, Ashland, OR, USA). A total of 
20,000 events were acquired within a primary gating based on cell scatter properties. 
Lymphocytes were gated based on their forward and side scattering parameters (FSC-H vs. 
SSC-H). The singlets were analyzed by the use of forward scatter area vs. forward scatter 
height dot-plot (FSC-A vs. FSC-H) and the frequencies (%) of CD19+ and CD3+ were 
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analyzed with specific antibodies (CD19-phycoerythrin (PE), CD19-allophycocyanine 
(APC) or CD3-PE vs. FSC-H) (Supplementary Fig. 1). Unstained samples and single-stain 
samples were used as controls for subsequent software compensation using the FlowJo 
analysis software compensation module. Carboxyfluorescein diacetate succinimidyl ester 
(CFSE) proliferation assays were analyzed with the FlowJo Proliferation Tool which finds 
the original population (100% of max CFSE), models the division by looking for peaks 
with diminishing fluorescence and calculates the percentage of divided cells. 
Annexin V and propidium iodide labelling 
After 48 h of in vitro stimulation, splenocytes were washed, resuspended in RPMI and were 
double-stained for annexin V (AV)-fluorescein isothiocyanate (FITC) and PI using the 
“Annexin-V Apoptosis Detection Kit I” (BD Pharmingen™, San Diego, CA, USA) 
according to the manufacturer‟s instructions. Incubation of cells in the presence of 
phytohemagglutinin (PHA) (1.25 µg/10
6
 cells) were used as controls. Stained cells were 
analyzed by flow cytometry. 
CFSE proliferation and lymphocyte phenotyping assays 
To track cell division, prior to in vitro culture, splenocytes were stained with 2.5 M of 
CFSE at 37ºC for 10 min, using the CellTrace™ CFSE Cell Proliferation Kit (Life 
Technologies, Eugene, OR, USA). CD3 cross-linking was used as a positive control for T 
cell proliferation. For this control, anti-CD3 monoclonal antibody (Purified Hamster anti-
mouse CD3e clone145-2C11, BD Pharmingen™, San Diego, CA, USA) was adsorbed to 
the culture plate (10 µg/ml) for 1 h at room temperature (RT) before the addition of 
splenocytes. After 48-72 h of in vitro stimulation, cells were collected by centrifugation and 
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washed with PBS 5% FBS. Then, cells were stained for 30 min on ice with anti-mouse 
CD19-APC and anti-mouse CD3-PE (BD Pharmingen™, San Diego, CA, USA) or anti-
mouse CD19-PE (Thermo Fisher, Rockford, IL, USA), washed with PBS 5% FBS and 
fixed with 3.6% formaldehyde for 15 min at RT. Fixed cells were analyzed by flow 
cytometry. 
Measurement of Ig secretion 
Total Ig and IgM were measured in supernatants of in vitro stimulated splenocytes and sera 
of inoculated mice by sandwich Enzyme-Linked ImmunoSorbent Assay (ELISA). 96-well 
flat bottomed plates were coated with goat anti-mouse IgG (which also reacts with the light 
chains of IgM and IgA) (Zymed Laboratories Inc., South San Francisco, CA, USA) 5 g/ml 
at 4ºC overnight. After blocking with 5% skimmed milk in PBS, plates were incubated for 
1h at RT with samples (50 l): supernatants in 2-fold serial dilutions from 1:16 to 1:128 
and sera diluted 1:10
5
. The mouse monoclonal antibody 2C5D6 (Bontempi et al., 2000) 
was used as quantification standard. Biotinylated goat anti-mouse IgG and biotinylated goat 
anti-mouse IgM followed by incubation with streptavidin peroxidase (Vector Labs, 
Burlingame, CA, USA) were used to detect total Ig and IgM, respectively. Color was 
developed with o-phenylenediaminedihydrochloride (OPD) and optical density (OD) was 
read at 490 nm using an ELISA microplate reader BioTek EL 808 (BioTek Instruments, 
Winooski, VT, USA). 
For detecting anti-Tc13Tul and MBP-specific antibodies, plates were coated with MBP or 
Tc13Tul 5 g/ml (50 l) at 4ºC overnight and the above protocol was followed from the 
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blocking step onwards. Supernatants and sera were tested in a dilution of 1:2 and 1:100, 
respectively. 
Measurement of cytokine secretion 
Supernatants of stimulated splenocytes were assayed for cytokine secretion by sandwich 
ELISA using the OptEIA™ Set for mouse interleukin 4 (IL-4) and IFN- (BD Biosciences, 
San Jose, CA, USA) and the mouse IL-17A (homodimer) ELISA Ready-SET-Go!® (e-
Biosiences, San Diego, CA, USA) according to the manufacturer‟s instructions. 
Tc13Tul binding assays to splenocytes 
Splenocytes were incubated for 30 min at 4°C with FITC-conjugated Tc13Tul or MBP (50 
g/ml). After binding assay, lymphocyte phenotyping was performed by staining with anti-
mouse CD19-PE (Thermo Fisher, Rockford, IL, USA) and anti-mouse CD3-PE (BD 
Pharmingen™, San Diego, CA, USA). Finally, cells were washed with PBS 5% FBS and 
fixed with 3.6% formaldehyde for 15 min at RT. Fixed cells were analyzed by flow 
cytometry. 
Studies of Tc13Tul effects in vivo 
Six-week-old male naïve BALB/c mice were inoculated intraperitoneally (i.p.) with a daily 
dose of 1 g/mouse/dose in PBS of Tc13Tul or MBP for three days. A control group was 
injected with the vehicle PBS. Sera were collected prior to inoculation and on days 4, 8 y 
11 after the first inoculation from the facial vein. Eleven days after the first inoculation 
mice were sacrificed and splenocytes were collected to be cultured in vitro. 
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Data are expressed as means + standard error (SE) and were derived from at least duplicate 
observations per experiment. All experiments were repeated at least twice. Differences 
among groups were evaluated by one- or two- way analysis of variance (ANOVA), as 
appropriate, followed by Bonferroni as post-test. Data were analyzed using GraphPad 
Prism 5.0 software (Graph Prism, San Diego, CA) and differences were considered 
significant when the p value was < 0.05. 
RESULTS 
Tc13Tul increases the viability of in vitro cultured splenocytes from BALB/c naïve mice 
and affects their lymphocyte population 
To evaluate primary immune responses triggered by Tc13Tul, primary splenocytes from 
naïve BALB/c mice were incubated for 24 h, 48 h and 72 h with recombinant Tc13Tul or 
EPKSA repeats and cell viability was assessed by exclusion of trypan blue staining. As 
Tc13Tul and EPKSA are fused to MBP and GST, respectively, incubation with these 
carrier proteins, in equivalent amounts to those present in the respective fusion proteins, 
was used to rule out their basal effects. Splenocytes cultured in the absence of stimulus 
(RPMI) and in the presence of the mitogen compound phytohemagglutinin (PHA) were 
used as negative and positive controls, respectively. Splenocyte viability decreases over 
time because lymphocytes are incapable of dividing unless they are stimulated by a 
mitogen (Sharon and Lis, 2004). Similarly to PHA, incubation with Tc13Tul showed a 
higher number of viable cells than controls. The effect of Tc13Tul was observed as early as 
24 h post-stimulation. Incubation with EPKSA repeats yielded a percentage of viable cells 
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similar to that obtained with controls. The lack of effect with the EPKSA C-terminal 
portion of Tc13Tul suggests that the region responsible for increasing splenocyte viability 
may be located at the N-terminal segment of the protein (Fig. 1A). These findings were 
confirmed by propidium iodide (PI) staining analyzed by flow cytometry (Supplementary 
Fig. 2). 
To determine whether the stimulation of splenocytes with Tc13Tul induced changes in 
lymphocyte populations, cells stimulated for 72 h were subjected to flow cytometry. The 
analysis of side (SSC-H) vs. forward (FSC-H) scatter dot plots showed that stimulation 
with Tc13Tul induced a lymphocyte population of increased size and granularity (named 
G2), which was similar to that produced by the mitogen PHA and a CD3-specific cross-
linking antibody. On the other hand, unstimulated cells or cells treated with MBP or 
EPKSA repeats only showed the basal lymphocyte population (named G1) (Fig. 1B). To 
investigate whether the G2 population was due to a lymphoproliferative effect of Tc13Tul, 
cellular proliferation of stimulated splenocytes was monitored by CFSE staining. The flow 
cytometry analysis of CFSE labeled-cells indicated cellular proliferation after stimulation 
with Tc13Tul but not with EPKSA repeats or the carrier proteins. The percentage of 
divided cells induced by Tc13Tul was significantly higher than that induced by MBP and 
the EPKSA repeats (Fig. 1C). Next, to evaluate the ability of Tc13Tul to induce apoptosis, 
stimulated splenocytes were double-stained with PI and annexin V (AV) and analyzed by 
flow cytometry. The analysis of quadrants AV-/PI-, AV+/PI- and AV+/PI+, performed on 
the lymphocyte population (G1+G2), showed that stimulation with Tc13Tul, like PHA, 
induced an increase in the number of cells in early apoptosis (AV+/PI-) at the expense of a 
decrease in viable cells (AV-/PI-). According to previous results, EPKSA repeats failed to 
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show this effect (Fig. 1D). These findings suggest that the increase in cell viability induced 
by Tc13Tul observed by trypan blue and PI staining may correspond to viable and early 
apoptotic cells. 
Given the evidence that Tc13Tul acts on the lymphocyte population, we then studied 
whether this antigen is able to interact with the lymphocyte surface. With this aim, binding 
of FITC-labeled Tc13Tul or MBP to these cells was evaluated by flow cytometry. Results 
showed a 2.6-fold higher labeling in the lymphocyte population with Tc13Tul-FITC than in 
that with MBP-FITC. To identify which lymphocyte population Tc13Tul binds to, bound 
cells were dyed for markers specific to B (CD19) and T (CD3) cells. Tc13Tul-FITC bound 
to 96.06 % of CD19+ cells and to 78.73 % of CD3+ cells, while the control protein MBP-
FITC bound to 34.6 % of CD19+ and to 11.1 % of CD3+ cells (Fig. 1E). These results 
suggest that Tc13Tul interacts with surface antigens on both B and T cells. 
Tc13Tul induces B cell proliferation, non-specific IgM and IFN- production in cultured 
splenocytes from naïve mice 
To characterize the lymphoproliferative effect of Tc13Tul, CFSE-labeled and stimulated 
splenocytes were phenotyped. The CFSE profile showed that Tc13Tul induced proliferation 
of B cells (CD19+) but not that of T cells (CD3+). Cross-linking with an anti-CD3 
monoclonal antibody was used as a positive control for T cell proliferation, which confirms 
the ability of these cells to divide when an appropriate stimulus is used. In contrast, MBP 
stimulation showed no significant differences respect to unstimulated cells (Fig. 2A and 
Supplementary Fig. 3). 
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Since Tc13Tul stimulation induced B-lymphocyte proliferation, we next evaluated whether 
this effect occurred concomitantly with either non-specific or Tc13Tul-specific Ig secretion. 
Supernatants of Tc13Tul-stimulated splenocytes showed higher total non-specific Ig levels 
than those of MBP-, EPKSA-, GST- or non-stimulated cells. Non-specific IgM levels were 
slightly lower than total Ig levels, indicating that these recombinant antigens mainly 
induced this Ig isotype (Fig. 2B). Tc13Tul-induced total Ig did not react with Tc13Tul and 
MBP by ELISA (Supplementary Fig. 4), demonstrating that these antibodies are not 
specific for these antigens. 
To study the cytokine profile induced by Tc13Tul, the levels of IFN- (Th1), IL-4 (Th2) 
and IL-17 (Th17) were measured in the supernatants of Tc13Tul-, MBP- and non-induced 
splenocytes. Neither IL-17 nor IL-4 were detected in the supernatants from MBP- and 
Tc13Tul-stimulated cells (Supplementary Fig. 5). In contrast, significant IFN- production 
was detected in the supernatants of Tc13Tul-induced splenocytes. No increase in IFN- was 
observed when cells were stimulated with recombinant EPKSA repeats (Fig. 2C). 
To rule out the possibility that the increase in non-specific Ig is due to potential endotoxin 
(lipopolysaccharide, LPS) contamination in the Tc13Tul preparation, splenocytes were 
treated with antigens in the absence or presence of colistin, an agent which disrupts 
bacterial LPS. Colistin affected neither MBP- nor Tc13Tul-induced Ig, indicating that the 
level of endotoxin in these recombinant proteins has no impact on this effect. As expected, 
colistin neither had effect on concanavalin A-induced Ig secretion, but significantly 
diminished the total Ig induced by LPS (Fig. 2D). 
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Tc13Tul stimulation is also observed in cultured naïve splenocytes from the LPS-
resistant C3H/HeJ mouse strain 
The effect of Tc13Tul on the proliferation of B cells and secretion of non-specific Ig and 
IFN- was also observed in splenocytes from naïve C3H/HeJ mice (Fig. 3). The 
particularity of the C3H/HeJ mouse strain is a mutation in the Toll-like receptor 4 (TLR-4), 
which makes it very resistant to LPS stimulation (Poltorak et al., 1998). Therefore, these 
results indicate that these effects are mediated by neither TLR-4 nor potential LPS 
contamination of recombinant proteins. 
In vivo administration of Tc13Tul to naïve BALB/c mice induces polyclonal Ig and IFN-
secretion 
To evaluate whether the effects of Tc13Tul observed in vitro are also relevant in vivo, 
BALB/c mice were inoculated with three doses of Tc13Tul (or MBP as control) and total Ig 
and IgM levels were evaluated in sera on days 4, 8 and 11 after the first inoculation. Sera of 
the Tc13Tul-inoculated group showed increased levels of total Ig from day 8 post-
inoculation (Fig. 4A). IgM levels were low and remained constant throughout the 
measurements (Supplementary Fig. 6), suggesting that in vivo Tc13Tul stimulation may 
induce mainly Igs of the IgG isotype. 
Eleven days after the inoculation, mice were sacrificed and their splenocytes were cultured 
in vitro for 72 h without stimulus (RPMI) or in the presence of MBP or Tc13Tul. Basal Ig 
secretion of splenocytes from Tc13Tul-inoculated mice was higher than that of splenocytes 
from control or MBP-inoculated animals (Fig. 4B white bars). Splenocytes from MBP-
inoculated mice increased Ig secretion only when they were in vitro stimulated with 
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Tc13Tul; however, Tc13Tul stimulation was not as high as that exerted on naïve 
splenocytes. This observation allowed us to speculate that the in vivo administration of 
MBP might have an inhibitory effect on B cells. Conversely, splenocytes from Tc13Tul-
inoculated mice and in vitro stimulated with Tc13Tul secreted higher Ig levels than 
splenocytes from naïve mice (Fig. 4B horizontal hatched bars), indicating an additive effect 
of in vivo and in vitro Tc13Tul administration. Splenocytes from Tc13Tul-inoculated mice 
also increased Ig secretion when they were in vitro stimulated with MBP (Fig. 4B vertical 
hatched bars). This suggests that Tc13Tul administered in vivo may have induced B cell 
activation and therefore, these cells were more reactive when in vitro stimulated also with 
the carrier protein MBP. The lack of Ig secretion by splenocytes from MBP-inoculated 
mice and in vitro stimulated with MBP validates that the one responsible for the stimulation 
of Ig production is the Tc13Tul portion of the recombinant protein, and not the carrier 
protein. Although the evaluation of polyclonal IgM secretion showed a profile similar to 
that of total Ig, basal IgM secretion in Tc13Tul-inoculated mice was not higher than that in 
control groups, suggesting that Tc13Tul administered in vivo might have induced IgG 
rather than IgM secretion by splenocytes (Fig. 4B). It is worth mentioning that neither 
Tc13Tul- nor MBP-specific antibodies were detected in sera or supernatants 
(Supplementary Fig. 6 and 7). IFN- production was only observed when splenocytes were 
in vitro stimulated with Tc13Tul. However, splenocytes from Tc13Tul-inoculated mice 
secreted higher IFN- levels than splenocytes from naïve and MBP-inoculated mice, 
indicating that the in vivo Tc13Tul administration enhanced the effect of the in vitro 
Tc13Tul stimulation (Fig. 4C horizontal hatched bars). 
DISCUSSION 
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The spleen is an important lymphoid organ that produces most of the non-specific immune 
responses characteristic of the acute phase of T. cruzi infection
 
(Bermejo et al., 2011). 
Several authors have documented the involvement of the TS group I member TcTS in 
triggering innate and innate-like responses in this organ (Gao et al., 2002; Todeschini et al., 
2002b; Bermejo et al., 2013). Our previous researches on Tc13 antigens in a BALB/c 
experimental model were focused on memory Tc13-specific immune responses. Studies of 
humoral and cellular responses induced by these antigens, either in the course of T. cruzi 
infection or as result of genetic and recombinant immunization with Tc13Tul antigen, 
suggest that the Tc13 family protein triggers mainly non-protective memory immunity 
(García et al., 2006; García et al., 2008). Therefore, the aim of the present work was to 
study primary immune responses induced by Tc13 antigens by evaluating their effect on 
splenocytes from naïve mice. 
All the experiments were performed with recombinant Tc13Tul antigen, which is fused to 
MBP from E. coli. As MBP and other bacterial components have effects on innate 
immunity (Akira et al., 2006; Liu et al., 2017) special controls were used to avoid wrong 
conclusions. Purified Tc13Tul was subjected to a further filtration step to eliminate possible 
low-molecular-weight contaminants. MBP induced from the wild type pMalp2 vector and 
purified in the same conditions as that used for recombinant Tc13Tul purification was 
thoroughly used to rule out the effect of the carrier protein. To rule out the effect of 
contaminant LPS: i- control assays were performed in the presence of colistin, a cationic 
polypeptide which binds and neutralize the LPS molecule (Gupta et al., 2009) and ii- in 
vitro Tc13Tul stimulation was also evaluated in splenocytes from naïve C3H/HeJ mice, a 
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mouse strain resistant to LPS activation (Poltorak et al., 1998). Neither of these strategies 
abrogated the effects observed, supporting that they are Tc13Tul-induced. 
Tc13Tul stimulation of naïve splenocytes showed mitogenic-like effects: it increased cell 
viability and, in the lymphocyte population, induced proliferation as well as apoptosis. 
These effects were even stronger than those induced by the mitogen PHA, a lectin that 
binds to lymphocyte membranes (Sharon and Lis, 2004). Therefore, Tc13Tul, like PHA, 
induced a net increase in cell number as a result of the lymphoproliferative effect. 
However, after 48 h of stimulation, the AV/PI analysis demonstrated that a great percentage 
of these cells had initiated the apoptotic process. Although cell viability and apoptosis are 
seemingly contradictory events, it should be taken into account that early apoptotic cells 
(AV+/PI-) still maintain the integrity of the plasma membrane and, therefore, are detected 
as viable by techniques using dyes that are excluded from viable cells, such as trypan blue 
and PI. It is important to note that although the definition of the term mitogen comes from 
its ability to stimulate lymphocyte mitosis (Nowell et al., 2000), it is known that mitogenic 
stimulation also leads to Fas/FasL-mediated apoptosis, thus limiting cell expansion 
(Miyawaki et al., 1992; Tu et al., 2000). 
In vitro stimulation with Tc13Tul of splenocytes from naïve BALB/c and C3H/HeJ mice 
induced B cell proliferation and polyclonal IgM secretion. IgM production by Tc13Tul in 
vitro stimulation is consistent with the low frequency of switching from IgM to IgG 
secretion detected in single B cell clones after treatment with mitogenic compounds 
(Andersson et al., 1978).
 
These effects were not observed when cells were stimulated with 
recombinant EPKSA repeats, suggesting that C-terminal repeats are not involved in these 
events. However, as the recombinant EPKSA used in this study belongs to the CAI strain of 
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T. cruzi and has some variations respect to the EPKSA portion of Tc13Tul (García et al., 
2003), it cannot be ruled out that the variations in the EPKSA units present in Tc13Tul are 
responsible for these effects and/or that the EPKSA portion as part of the whole Tc13 
molecule has a different conformation that favours its activity. Similar studies using TcTS 
have indicated that the polyclonal B cell mitogenic activity is present in its C-terminal 
SAPA repeats rather than in its N-terminal domain (Gao et al., 2002). These results indicate 
that SAPA and EPKSA repeats might diverge in their role in early immunity, although they 
share other features such as immunodominance and the ability to increase the half-life of 
proteins in blood (Burns et al., 1992; Buscaglia et al., 1999). 
Tc13Tul also induced polyclonal non-specific Ig stimulation by in vivo administration. It is 
worth mentioning that, based on previous studies on TcTS (Da Silva et al., 1998; Gao et al., 
2002; Aridgides et al., 2013; Salvador et al., 2014), in vivo administration of Tc13Tul was 
carried out in the absence of any adjuvant that could mask or potentiate its effect. Tc13Tul-
administerd mice showed increased non-specific IgG in sera from day 8 post-inoculation 
and increased total Ig secretion when their splenocytes were in vitro cultured for 72 h. 
Neither of these antibodies showed specificity for Tc13Tul or MBP. Other T. cruzi antigens 
also failed to induce specific antibodies when administered to mice with similar protocols 
(Da Silva et al., 1998; Gao et al., 2002). In these studies, the lack of specific responses was 
ascribed to the absence of adjuvant and insufficient time to trigger antigen-specific 
antibodies through T-B cell interaction. These explanations can also be applied to the non-
specific effect observed with Tc13Tul and MBP in vivo administration. In the spleen, B-1 
and marginal zone B cells have shown to be the main source of T-independent production 
of IgM antibodies in the early stage of the immune response, although they are also able to 
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undergo IgG class switching (Martin et al., 2001). These B lymphocyte subsets, classified 
as “innate-like” B cells, act as sentinels to rapidly respond to blood-borne antigens by 
expressing polyreactive less specific B-cell receptors (BCRs) and having rapid proliferation 
rates (Romero-Ramírez et al., 2019). The basal level of non-specific IgM secretion by 
splenocytes from Tc13Tul-inoculated mice and the additive effect observed when they are 
in vitro stimulated with Tc13Tul suggest that the primary immune mechanism triggered by 
Tc13Tul may include stimulation of innate-like B cells. Although splenocytes of Tc13Tul-
administered mice showed increased antibody production, the B/T ratios in spleens were 
not increased at the time of sacrifice (1.45±0.0981 and 1.21±0.0641 in MBP- and Tc13Tul-
administerd mice, respectively, p=0.066). This could be due to the fact that the i.p. 
inoculation route could generate a greater immune response in lymph nodes than in the 
spleen (Schmidt et al., 2016). 
In vitro stimulation with Tc13Tul of splenocytes from naïve BALB/c induced IFN- but not 
IL-4 or IL-17 secretion. Moreover, the in vivo Tc13Tul administration potentiated the 
secretion of IFN-induced by the in vitro Tc13Tul stimulation. Previous studies have 
shown that in vitro stimulation of splenocytes with TcTS induces secretion of IFN-, IL-6 
(Gao et al., 2002) and IL-17 (Bermejo et al., 2013). TcTS has been identified as the sole T. 
cruzi molecule required for an innate-like IL-17 production by B cells, a process that 
involves TS activity (Bermejo et al., 2013). Therefore, the lack of IL-17 induction by 
Tc13Tul is an expected result, also due to the absence of Tyr342, which is essential for 
enzymatic activity. Regarding IFN-, it is known that this cytokine plays an important role 
in experimental T. cruzi infection by inducing macrophage activation, which controls 
intracellular parasite replication (Gazzinelli et al., 1992). In T. cruzi-infected mice, NK and 
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NK T cells are the main source of initial IFN- production (Cardillo et al., 1996; Duthie et 
al., 2005). Although splenic IFN-𝛾-producing B cells have not yet been studied in T. cruzi 
infection, they have been identified in mice challenged with several pathogens as Listeria 
monocytogenes and Escherichia coli (Bao et al., 2014). Thus, it would be interesting to 
perform further studies to define the population involved in IFN- production by Tc13Tul 
induction. In relation to the mechanism of IFN- production by Tc13Tul, the fact that this 
antigen also induced IFN- secretion in naïve splenocytes from C3H/HeJ mice suggests that 
this effect is not mediated by TLR4. This is an interesting result because TLR4 signaling is 
required for optimal IFN- production as part of the innate immune response against T. 
cruzi (Oliveira et al., 2010). 
In conclusion, our studies support that the possible participation of Tc13Tul in the early 
phase of the immune response against T. cruzi is mainly exerted in phenomena related to 
the evasion of the immune system, such as polyclonal B cell expansion and non-specific Ig 
production. In contrast, as IFN- is an important factor involved in the resistance to T. 
cruzi, this effect may be considered in favor to the host. However, it has been suggested 
that the excess of nitric oxide induced by IFN- may be involved in down-regulating the 
immune responses against the parasite (Martins et al., 1999). The mechanism by which 
Tc13Tul produces these effects was not studied in this work. Affinity assays showed that 
Tc13Tul binds the B cell surface but also, to a lesser extent, the T cell surface. As this 
antigen has no TS activity, a possible hypothesis to be further evaluated is that all these 
effects could be mediated by the lectin motif present in the amino terminal region of this 
antigen (Buschiazzo et al., 2002; Todeschini et al., 2002a; Todeschini et al., 2004). In this 
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regards, studies on TcTS have demonstrated its ability to induce stimulatory responses on T 
and B cells through the engagement of host sialylated glycoproteins, such as CD43 and 
CD45, respectively (Todeschini et al., 2002a,b; Bermejo et al., 2013). Therefore, these 
molecules are good candidates to take into account for future studies on the mechanism of 
action of Tc13Tul. 
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Figure 1: Effect of Tc13Tul on the viability of in vitro cultured splenocytes from naïve 
BALB/c mice and their lymphocyte population. 
Splenocytes were cultured for the indicated times with Tc13Tul (6 µg/10
6
 cells), EPKSA (6 
µg/10
6
 cells) or the equivalent amounts of their respective carrier proteins, MBP (2.2 
µg/10
6
 cells) and GST (1.5 µg/10
6
 cells). Cells cultured in the absence of stimulus (RPMI) 
and in the presence of PHA (1.25 µg/10
6
 cells) or anti-CD3 monoclonal antibody (10 
µg/ml) were used as controls. (A) Surviving cells were evaluated by the trypan blue 
exclusion assay and analyzed by optical microscopy. The initial cell inoculum of 2x10
6 
cells/ml was considered as 100% of viable cells. (B) Splenocytes stimulated with the 
antigens for 72 h were analyzed by flow cytometry. Lymphocytes were gated based on 
https://doi.org/10.1017/S0031182020000864




forward scattering (FSC-H) and side scattering (SSC-H). Populations of basal (G1) and 
enlarged (G2) lymphocytes are indicated in the dot plots. (C) Splenocytes were stained with 
CFSE prior to stimulation, stimulated with antigens for 72 h and analyzed by flow 
cytometry. Histograms of CFSE-stained cells in the gated population G1+G2 showing the 
percentages of divided cells calculated with the FlowJo Proliferation Tool. (D) After 48 h 
of stimulation, splenocytes were double-stained with annexin V-FITC (AV) and propidium 
iodide (PI) and analyzed by flow cytometry in the gated population G1+G2. (E) 
Splenocytes from naïve BALB/c mice were incubated with FITC-Tc13Tul or FITC-MBP, 
subsequently stained with anti-CD19-PE or anti-CD3-PE and analyzed by flow cytometry 
gated on lymphocyte population. Dot plots (CD19+ and CD3+) of FITC-stained 
lymphocytes and their quantification are shown. Representative data of at least two 
independent experiments are shown. Data are the means + SE. Significance was determined 
by two-way ANOVA and Bonferroni as post-test. *, p<0.05, **, p<0.01, ***, p<0.001 and 
****, p<0.0001 respect to negative controls (RPMI, MBP and/or GST). 
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Figure 2: Effect of Tc13Tul on lymphocyte proliferation, polyclonal Ig and IFN- 
secretion in cultured splenocytes from naïve BALB/c mice. 





 cells) or medium (RPMI). After stimulation, cells were stained with anti-
CD19-APC and anti-CD3-PE and analyzed by flow cytometry. (A) Dot plots showing 
double-stained (CFSE/CD19-APC and CFSE/CD3-PE) cells on lymphocyte gate. (B) Total 
Ig and IgM secretion evaluated by ELISA in splenocyte supernatants. (C) IFN- secretion 
evaluated by ELISA in splenocyte supernatants. **, p<0.01 and ***, p<0.001 respect to 
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negative controls (RPMI, MBP and/or GST). (D) Total Ig secretion evaluated by ELISA in 
supernatants of splenocytes induced for 72 h with the antigens (MBP or Tc13Tul), 
lipopolysaccharide (LPS) (5 g/ml) or concanavalin A (CON A) (10 g/ml) in the absence 
or presence of colistin (10 g/ml), an agent which interferes with LPS activity. 
Representative data of at least two independent experiments are shown. Data are the means 
+ SE. Significance was determined by ANOVA and Bonferroni as post-test. ***, p<0.001 
respect to negative controls (RPMI, MBP and/or GST) and &, p<0.01 compared with 
absence of colistin. 
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Figure 3: Effect of Tc13Tul in cultured naïve splenocytes from the LPS-resistant 
C3H/HeJ mouse strain 
Splenocytes from naïve C3H/HeJ mice were stained with CFSE and cultured for 72 h with 
Tc13Tul (6 µg/10
6
 cells), MBP (2.2 µg/10
6
 cells) or medium (RPMI). (A) After 
stimulation, cells were stained with anti-CD19-PE and proliferation of CD19+ cells was 
analyzed by flow cytometry on lymphocyte gate. The percentage of divided cells was 
calculated with the FlowJo Proliferation Tool. (B) Total Ig and (C) IFN- evaluated in 
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splenocyte supernatants by ELISA. Representative data of at least two independent 
experiments are shown. Data are the means + SE. Significance was determined by one-way 
ANOVA and Bonferroni as post-test. **, p<0.01 and ***, p<0.001 respect to RPMI and 
MBP. 
 
Figure 4: Effect of Tc13Tul after in vivo administration to naïve BALB/c mice. 
(A) Total Ig levels evaluated by ELISA in mouse sera injected with buffer (naïve) and 
inoculated with MBP or Tc13Tul (a daily i.p. dose of 1g/mouse for three days). Sera were 
collected for evaluation prior to the injection and 4, 8 and 11 days post-injection (DPI). 
Individually for each mouse (n=3), the ratio between Ig amounts in serum at the indicated 
days and their amounts prior to antigen injection was calculated. *, p<0.05 and **, p<0.01 
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respect to the naïve group. (B) Total Ig and IgM and (C) IFN-levels in supernatants of 
pooled splenocytes from naïve, MBP- and Tc13Tul-inoculated mice cultured in vitro for 72 
h without stimulation (RPMI) or stimulated with MBP or Tc13Tul. * and •, p<0.05 respect 
to in vitro cultured splenocytes without stimulation and stimulated with MBP, respectively. 
&, p<0.05 respect to splenocytes from naïve mice.  Data represent the means + SE. 
Significance was determined by two-way ANOVA and Bonferroni as post-test.  
https://doi.org/10.1017/S0031182020000864
Downloaded from https://www.cambridge.org/core. Uppsala Universitetsbibliotek, on 10 Jun 2020 at 13:33:20, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
